ASSOCIATIONS OF METABOLIC SUBTYPES OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE WITH RISK OF CARDIOVASCULAR MORTALITY AND ALL-CAUSE MORTALITY IN THE UNITED STATES

被引：0
|
作者：
Zeng, Guyu [1 ]
Wang, Peizhi [1 ]
Yuan, Jinqing [1 ]
机构：
[1] Fuwai Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1453-207
引用
收藏
页码：1968 / 1968
页数：1
相关论文
共 50 条
  • [21] Trends in the Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in the United States
    Wong, Robert J.
    Cheung, Ramsey
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : E610 - E613
  • [22] Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records
    Drozdov, Ignat
    Szubert, Benjamin
    Rowe, Ian A.
    Kendall, Timothy J.
    Fallow, Jonathan A.
    ANNALS OF HEPATOLOGY, 2024, 29 (05)
  • [23] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Min Kyu Kang
    Yu Rim Lee
    Se Young Jang
    Won Young Tak
    Young Oh Kweon
    Jeong Eun Song
    Rohit Loomba
    Soo Young Park
    Jung Gil Park
    Hepatology International, 2023, 17 : 626 - 635
  • [24] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Song, Jeong Eun
    Loomba, Rohit
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 626 - 635
  • [25] FERRITIN IS ASSOCIATED WITH INCREASED MORTALITY, PROGRESSION TO CIRRHOSIS, AND DEVELOPMENT OF CARDIOVASCULAR DISEASE IN METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Suresh, Deepika
    Miller, Matthew
    Wijarnpreecha, Karn
    Chen, Vincent
    HEPATOLOGY, 2022, 76 : S714 - S715
  • [26] Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease
    Goh Eun Chung
    Su Jong Yu
    Jeong-Ju Yoo
    Yuri Cho
    Kyu-na Lee
    Dong Wook Shin
    Donghee Kim
    Yoon Jun Kim
    Jung-Hwan Yoon
    Kyungdo Han
    Eun Ju Cho
    BMC Medicine, 21
  • [27] Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease
    Chung, Goh Eun
    Yu, Su Jong
    Yoo, Jeong-Ju
    Cho, Yuri
    Lee, Kyu-na
    Shin, Dong Wook
    Kim, Donghee
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Han, Kyungdo
    Cho, Eun Ju
    BMC MEDICINE, 2023, 21 (01)
  • [28] STATIN USE WITH CARDIOVASCULAR DISEASE AND ALL-CAUSE MORTALITY IN PATIENTS WITH HYPERTENSION, METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE, AND OBESITY: A POPULATION-BASED COHORT STUDY
    Abaalkhail, Arunkumar Krishnan Faisal
    Althwanay, Aldanah
    Woreta, Tinsay
    Alqahtani, Saleh
    HEPATOLOGY, 2024, 80 : S894 - S895
  • [29] Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
    Jung, Han Na
    Jung, Chang Hee
    DIABETES & METABOLISM JOURNAL, 2023, 47 (02) : 198 - 200
  • [30] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiao-Dong Zhou
    Jingjing Cai
    Giovanni Targher
    Christopher D. Byrne
    Michael D. Shapiro
    Ki-Chul Sung
    Virend K. Somers
    C. Anwar A. Chahal
    Jacob George
    Li-Li Chen
    Yong Zhou
    Ming-Hua Zheng
    Cardiovascular Diabetology, 21
12345